Our results have indicated that SYT possesses the potential of improving obesity-associated T2D through the regulation of lipid-related metabolites via the JAK/STAT signaling pathway in the liver (Figure 8). This evidence concerns the gene SOAT1 and type 2 diabetes mellitus.